Dolby Laboratories reported a revenue of $305 million for Q4 2024, up from $291 million in Q4 2023. GAAP net income increased to $59 million, or $0.61 per diluted share, compared to $9 million, or $0.09 per diluted share, in the prior year quarter. Non-GAAP net income was $78 million, or $0.81 per diluted share, compared to $64 million, or $0.65 per diluted share, for the fourth quarter of fiscal 2023.
Total revenue increased to $305 million compared to $291 million in Q4 2023.
GAAP net income rose to $59 million, or $0.61 per diluted share, from $9 million, or $0.09 per diluted share, year-over-year.
Non-GAAP net income was $78 million, or $0.81 per diluted share, up from $64 million, or $0.65 per diluted share, in the prior year quarter.
Dolby repurchased approximately 251,000 shares of its common stock.
Dolby provided estimates for its first quarter and full year of fiscal 2025. Q1 revenue is expected to range from $330 million to $360 million. Full year revenue is expected to range from $1.33 billion to $1.39 billion.